Codon 249 mutation in exon 7 of p53 gene in plasma DNA: Maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 692-695

  Huang, Xing Hua ^a,c   Sun, Lu Hong ^b   Lu, Dong Dong ^b   Sun, Yan ^c   Ma, Li Jie ^a   Zhang, Xi Ran ^b   Huang, Jian ^c   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

^c QIDONG LIVER CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ARGININE; BIOLOGICAL MARKER; DNA; GUANINE; HEPATITIS B SURFACE ANTIGEN; PROTEIN P53; SERINE; THYMIDINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CHINA; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DNA EXTRACTION; DNA PURIFICATION; EARLY DIAGNOSIS; EXON; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; PLASMA; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

EID: 0037963062     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.692     Document Type: Article

References (35)

1. Jackson PE, Groopman JD. Aflatoxin and liver cancer. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 545-555
2. Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E. Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 1992; 84: 1638-1641
3. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 1997; 57: 3471-3477
4. Park US, Su JJ, Ban KC, Qin L, Lee EH, Lee YI. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1. Gene 2000; 251: 73-80
5. Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; Implications for a gain-of-function during the formation of hepatocellular carcinoma. Oncogene 2000; 19: 3717-3726
6. Wang JS, Huang T, Su J, Liang F, Wei Z, Liang Y, Luo H, Kuang SY, Qian GS, Sun G, He X, Kensler TW, Groopman JD. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2001; 10: 143-146
7. Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci U S A 2002; 99: 6655-6660
8. Zhang F, Zhu Y, Sun Z. Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China. Zhonghua Zhongliu Zazhi 1998; 20: 18-21
9. Zhu M, Dai Y, Zhan R. HBxAg enhanced p53 protein accumulation in hepatoma cells. Zhonghua Binglixue Zazhi 1999; 28: 31-34
10. Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, Wang JB, Wu Y, Kensler TW, Vogelstein B, Groopman JD. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res 2001; 61: 33-35
11. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 7435-7451
12. Niu ZS, Li BK, Wang M. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World J Gastroenterol 2002; 8: 822-826
13. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 1991; 350: 427-428
14. Li D, Cao Y, He L, Wang NJ, Gu JR. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 1993; 14: 169-173
15. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994; 54: 281-285
16. Deng ZL, Ma Y. Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma. World J Gastroenterol 1998; 4: 28-29
17. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, Trepo C, Brechot C, Hainaut P, Montesano R. 249 Ser- p53 mutations in plasm DNA of patients with hepatocellular carcinoma from the Gambia. J Natl Cancer Inst 2000; 92: 148-153
18. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999; 59: 71-73
19. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996; 2: 1033-1035
20. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996; 2: 1035-1037
21. Martins C, Kedda MA, Kew MC. Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks. World J Gastroenterol 1999; 5: 470-476
22. Jiang W, Lu Q, Pan G. p53 gene mutation in hepatocellular carcinoma. Zhonghua Waike Zazhi 1998; 36: 531-532
23. Yang M, Zhou H, Kong RY, Fong WF, Ren LQ, Liao XH, Wang Y, Zhuang W, Yang S. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China. Mutat Res 1997; 381: 25-29
24. Shimizu Y, Zhu JJ, Han F, Ishikawa T, Oda H. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiangsu province of China. Int J Cancer 1999; 82: 187-190
25. Ming L, Yuan B, Thorgeirsson SS. Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China. Zhonghua Zhongliu Zazhi 1999; 21: 122-124
26. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomark Prev 1994; 3: 3-10
27. Liu H, Wang Y, Zhou Q, Gui SY, Li X. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. World J Gastroenterol 2002; 8: 480-482
28. Qian GS, Kuang SY, He X, Groopman JD, Jackson PE. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP. Cancer Epidemiol Biomarkers Prev 2002; 11: 1126-1129
29. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE, Farthing MJ. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997; 112: 1114-1120
30. Stroun M, Anker P, Beljanski M, Henri J, Lederrey C, Ojha M, Maurice PA. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res 1978; 38: 3546-3554
31. Goessl C, Haicappell R, Munker R, Anker R, Anker P, Stroun M, Krause H, Muller M, Miller K. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 1998; 58: 4728-4732
32. Minouchi K, Kaneko S, Kobayashi K. Mutation of p53 gene in regenerative nodules in cirrhotic liver. J Hepatol 2002;37:231-239
33. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385-392
34. Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Ji Y, Huang LW, Jia HL, Sun HC, Wang L. P53 immunohistochemical scoring: An independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol 2002; 8: 459-463
35. Makarananda K, Pengpan U, Srisakulthong M, Yoovathaworn K, Sriwatanakul K. Monitoring of aflatoxin exposure by biomarkers. J Toxicol Sci 1998; 23: 155-159